Syros Pharmaceuticals Inc.

NASDAQ:SYRS   4:00:00 PM EDT
3.96
+0.13 (+3.39%)
4:09:11 PM EDT: $4.01 +0.05 (+1.26%)
Earnings Announcements

Syros Pharmaceuticals Inc Q3 Loss Per Share $3.21

Published: 11/14/2022 12:46 GMT
Syros Pharmaceuticals Inc. (SYRS) - Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update.
Q3 Loss per Share $3.21.
Revenues Were $3.9 Million for Q3 of 2022 Versus $5.7 Million for Q3 of 2021.
Q3 Earnings per Share View $-4.01, Revenue View $5.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.85 Million
Adjusted EPS is expected to be -$1.23

Next Quarter Revenue Guidance is expected to be $4 Million
Next Quarter EPS Guidance is expected to be -$1.24

More details on our Analysts Page.